DE602006008349D1 - Quaternäre 3-amido, n-methylpyridiniumsalze als entzündungshemmende mittel - Google Patents
Quaternäre 3-amido, n-methylpyridiniumsalze als entzündungshemmende mittelInfo
- Publication number
- DE602006008349D1 DE602006008349D1 DE602006008349T DE602006008349T DE602006008349D1 DE 602006008349 D1 DE602006008349 D1 DE 602006008349D1 DE 602006008349 T DE602006008349 T DE 602006008349T DE 602006008349 T DE602006008349 T DE 602006008349T DE 602006008349 D1 DE602006008349 D1 DE 602006008349D1
- Authority
- DE
- Germany
- Prior art keywords
- inflammatory
- compounds
- amido
- quaternary
- anion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- PQBAWAQIRZIWIV-UHFFFAOYSA-N N-methylpyridinium Chemical class C[N+]1=CC=CC=C1 PQBAWAQIRZIWIV-UHFFFAOYSA-N 0.000 title 1
- 229940121363 anti-inflammatory agent Drugs 0.000 title 1
- 239000002260 anti-inflammatory agent Substances 0.000 title 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 5
- 150000001875 compounds Chemical class 0.000 abstract 3
- 150000001450 anions Chemical class 0.000 abstract 2
- 150000001768 cations Chemical class 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 238000002360 preparation method Methods 0.000 abstract 2
- LDHMAVIPBRSVRG-UHFFFAOYSA-O 1-methylnicotinamide Chemical compound C[N+]1=CC=CC(C(N)=O)=C1 LDHMAVIPBRSVRG-UHFFFAOYSA-O 0.000 abstract 1
- 230000001760 anti-analgesic effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pain & Pain Management (AREA)
- Pharmacology & Pharmacy (AREA)
- Rheumatology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH19542005 | 2005-12-09 | ||
| PCT/CH2006/000672 WO2007065281A1 (en) | 2005-12-09 | 2006-11-29 | Quaternary 3 -amido, n-methylpyridinium salts as anti -inflammatory agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE602006008349D1 true DE602006008349D1 (de) | 2009-09-17 |
Family
ID=37913716
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602006008349T Expired - Fee Related DE602006008349D1 (de) | 2005-12-09 | 2006-11-29 | Quaternäre 3-amido, n-methylpyridiniumsalze als entzündungshemmende mittel |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20080249140A1 (de) |
| EP (1) | EP1963270B1 (de) |
| AT (1) | ATE438625T1 (de) |
| CA (1) | CA2629913A1 (de) |
| DE (1) | DE602006008349D1 (de) |
| MX (1) | MX2008007259A (de) |
| WO (1) | WO2007065281A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2702898C2 (ru) * | 2014-09-10 | 2019-10-14 | Гск Консьюмер Хелткер С.А. | Композиции диклофенака натрия для местного применения |
| ES2967074T3 (es) * | 2016-07-18 | 2024-04-25 | Pharmena S A | 1 metilnicotinamida para el tratamiento de una enfermedad cardiovascular |
| CA3055159A1 (en) | 2017-03-07 | 2018-09-13 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd | Topical delivery systems for active compounds |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3340028A1 (de) * | 1983-11-03 | 1985-05-15 | Josef Dipl.-Chem. Dr.Rer.Nat. Klosa | Neues salicylsaeuresalz |
| PL190755B1 (pl) * | 1999-01-07 | 2006-01-31 | Pharmena Sp Z Oo | Preparat do leczenia i profilaktyki chorób skóry |
| PL364348A1 (en) * | 2004-01-12 | 2005-07-25 | PHARMENA Sp.z o.o. | Application of quaternary pyridine salts as vessel protection agent |
-
2006
- 2006-11-29 WO PCT/CH2006/000672 patent/WO2007065281A1/en active Application Filing
- 2006-11-29 DE DE602006008349T patent/DE602006008349D1/de not_active Expired - Fee Related
- 2006-11-29 AT AT06804891T patent/ATE438625T1/de not_active IP Right Cessation
- 2006-11-29 US US12/094,169 patent/US20080249140A1/en not_active Abandoned
- 2006-11-29 MX MX2008007259A patent/MX2008007259A/es not_active Application Discontinuation
- 2006-11-29 EP EP06804891A patent/EP1963270B1/de not_active Not-in-force
- 2006-11-29 CA CA002629913A patent/CA2629913A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| MX2008007259A (es) | 2008-09-23 |
| EP1963270B1 (de) | 2009-08-05 |
| EP1963270A1 (de) | 2008-09-03 |
| US20080249140A1 (en) | 2008-10-09 |
| ATE438625T1 (de) | 2009-08-15 |
| WO2007065281A1 (en) | 2007-06-14 |
| CA2629913A1 (en) | 2007-06-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1120141T1 (el) | Παραγωγο βενζαμιδιου ως αναστολεας απακετυλασης ιστονης με ισχυρη διαφοροποιητικη και αντιπολλαπλασιαστικη δραστικοτητα | |
| CY1115058T1 (el) | Παραγωγα 1,2,3- τριαζολης για χρηση ως αναστολεις στεατοϋλο-coa δεσατουρασης | |
| BRPI0908353B8 (pt) | composto ou um sal farmaceuticamente aceitavel do mesmo e composição farmaceutica | |
| BR112012008317A2 (pt) | produto de liberação sustentada compreendendo uma combinação de uma amina não-opioide e uma droga anti-inflamatória não-esteroidal | |
| UA108363C2 (uk) | Похідні імінотіадіазиндіоксиду як інгібітори bace, композиція на їх основі і їх застосування | |
| BRPI0612287A8 (pt) | composição para uso farmacêutico no tratamento de doenças através da medicina nuclear e métodos de uso e para modulação de atividade de receptor nuclear | |
| BR112014031730A2 (pt) | entidades químicas, composições farmacêuticas, compostos ou sais farmaceuticamente aceitáveis dos mesmos, usos de entidades químicas ou composições e métodos para tratar doenças, distúrbios ou condições médicas mediadas pela atividade enzimática de pde1 e para modular a atividade da enzima pde1 | |
| BRPI0408486A (pt) | derivados de biciclopirazol ativos como inibidores da cinase, processo para a sua preparação e composições farmacêuticas compreendendo-os | |
| JP2012144490A (ja) | 外用組成物 | |
| ATE425961T1 (de) | Salze substituierter allophansaureester und deren verwendung in arzneimitteln | |
| BRPI0607614A2 (pt) | sal de besilato da 7-(2-(4-3-trifluorometil-fenil)-1,2,3,6-tetrahidropirid- 1-il)etil) isoquinoleìna, o respectivo medicamento, composição farmacêutica e uso | |
| BR112014028813A2 (pt) | 5-amino[1,4]tiazinas como inibidores bace1 | |
| NO20084478L (no) | Konjugerte lipidderivater | |
| BRPI0607918A2 (pt) | tetraidro-piridoazepin-8-onas e compostos relacionados para o tratemento da esquizofrenia. | |
| ATE438625T1 (de) | Quaternäre 3-amido, n-methylpyridiniumsalze als entzündungshemmende mittel | |
| NO20023551D0 (no) | Ibuprofen-inneholdende aktivt middel-preparat | |
| HRP20060079A2 (en) | Benzoquinolizine-2-carboxylic acid arginine salt tetrahydrate | |
| Li et al. | Synthesis and antitumor evaluation of a highly potent cytotoxic DNA cross-linking polyamine analogue, 1, 12-diaziridinyl-4, 9-diazadodecane | |
| EA201000701A1 (ru) | 4-[4-(2-адамантилкарбамоил)-5-трет-бутилпиразол-1-ил]бензойная кислота-465 | |
| ATE460934T1 (de) | Pharmazeutische zubereitungen von ciprofloxacin | |
| ATE378335T1 (de) | Chirale fluorochinolizinon arginine salze | |
| UY30126A1 (es) | Una nueva sal farmaceuticamente aceptable de 2-hidroxi-3-(5-(morfolin-4-ilmetil)-piridin-2-l)1h-indol-5-carbonitrilo, procedimientos para su preparacion, composiciones que la contienen yaplicaciones | |
| Sharma et al. | Design of Fmoc-Phenylalanine Nanofibrillar Hydrogel and Mechanistic Studies of Its Antimicrobial Action against Both Gram-Positive and Gram-Negative Bacteria | |
| HRP20050815A2 (en) | 2-(butyl-1-sulfonylamino)-n-[1(r)-(6-methoxy-pyridin-3-yl)-propyl]-benzamid, the use thereof in the form of drug an pharmaceutical preparations containing said compound | |
| ATE490233T1 (de) | Neuartige rar-rezeptoragonisten-liganden und deren verwendung in der humanmedizin und kosmetik |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |